Papers from every journal, all in one place. Create custom feeds.
TIVA confers no recovery advantage over inhalational anesthesia; supports either approach in older adults undergoing major noncardiac surgery.

Anesthesiologist, Unknown
First of all, congratulations both to Joyce, Shaman, and the people group, you know, and the U.K. for actually executing this trial and recruiting. So it's a fabulous feat. I think as you said, it's absolutely a positive study... in the sense that it's reassuring that the techniques that are available to us as a community... it's absolutely reassuring that whatever anesthetic choice we have available to us, patients will do well.
May support phenotype-guided sacubitril/valsartan in HFpEF; leaves open prospective validation before practice change.

Selective angiography may suffice without excess major complications; leaves open whether routine use improves outcomes in randomized settings.

May enhance preoperative risk stratification with coronary CT; extends observational data but leaves open need for prospective validation.

Supports M-TEER feasibility in LVEF<20%; leaves open confirmation by randomized trials.

National AF hospitalization trends reported; leaves open causal factors and targeted interventions to reduce readmissions.

Comorbidity indices add nothing to EuroSCORE II for TAVI risk stratification; leaves open whether individual organ-reserve markers merit prospective testing.

May inform CV risk stratification in oncology; extends single-cancer AI reviews to diverse populations with clinical data.

Provides Delphi-based minimum standards for European paediatric anaesthesia training; leaves open whether adoption improves safety or outcomes.

TS approach linked to longer operative times and higher pacemaker risk than LA in MVS; extends pooled evidence favoring LA to minimize complications.
